摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,4aR,5aS,9aR,10aS)-9a-methyl-2-phenyl-4a,5a,6,9a,10,10a-hexahydro-4H-pyrano[2',3':5,6]pyrano[3,2-d][1,3]dioxine | 1373516-85-8

中文名称
——
中文别名
——
英文名称
(2R,4aR,5aS,9aR,10aS)-9a-methyl-2-phenyl-4a,5a,6,9a,10,10a-hexahydro-4H-pyrano[2',3':5,6]pyrano[3,2-d][1,3]dioxine
英文别名
——
(2R,4aR,5aS,9aR,10aS)-9a-methyl-2-phenyl-4a,5a,6,9a,10,10a-hexahydro-4H-pyrano[2',3':5,6]pyrano[3,2-d][1,3]dioxine化学式
CAS
1373516-85-8
化学式
C17H20O4
mdl
——
分子量
288.343
InChiKey
AUENIARFRSIJBJ-DMRKSPOLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.95
  • 重原子数:
    21.0
  • 可旋转键数:
    1.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    36.92
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    (2R,4aR,5aS,9aR,10aS)-9a-methyl-2-phenyl-4a,5a,6,9a,10,10a-hexahydro-4H-pyrano[2',3':5,6]pyrano[3,2-d][1,3]dioxine咪唑4-二甲氨基吡啶四丙基高钌酸铵偶氮二异丁腈 、 dimethyl sulfide borane 、 palladium on activated charcoal 、 camphor-10-sulfonic acid 、 potassium tert-butylate氢气三正丁基氢锡sodium methylate 、 palladium diacetate 、 4-甲基苯磺酸吡啶 、 zinc trifluoromethanesulfonate 、 二异丁基氢化铝caesium carbonateN-甲基吗啉氧化物三乙胺三苯基膦2,3-二氯-5,6-二氰基-1,4-苯醌lithium hexamethyldisilazane 作用下, 以 四氢呋喃甲醇乙醚乙醇正己烷二氯甲烷N,N-二甲基甲酰胺甲苯乙腈 为溶剂, 反应 117.34h, 生成
    参考文献:
    名称:
    Design and Synthesis of Skeletal Analogues of Gambierol: Attenuation of Amyloid-β and Tau Pathology with Voltage-Gated Potassium Channel and N-Methyl-d-aspartate Receptor Implications
    摘要:
    Gambierol is a potent neurotoxin that belongs to the family of marine polycyclic ether natural products and primarily targets voltage-gated potassium channels (K-v channels) in excitable membranes. Previous work in the chemistry of marine polycyclic ethers has suggested the critical importance of the full length of polycyclic ether skeleton for potent biological activity. Although we have previously investigated structure-activity relationships (SARs) of the peripheral functionalities of gambierol, it remained unclear whether the whole polycyclic ether skeleton is needed for its cellular activity. In this work, we designed and synthesized two truncated skeletal analogues of gambierol comprising the EFGH- and BCDEFGH-rings of the parent compound, both of which surprisingly showed similar potency to gambierol on voltage gated potassium channels (K-v) inhibition. Moreover, we examined the effect of these compounds in an in vitro model of Alzheimer's disease (AD) obtained from triple transgenic (3xTg-AD) mice, which expresses amyloid beta (A beta) accumulation and tau hyperphosphorylation. In vitro preincubation of the cells with the compounds resulted in significant inhibition of K+ currents, a reduction in the extra- and intracellular levels of A beta, and a decrease in the levels of hyperphosphorylated tau. In addition, pretreatment with these compounds reduced the steady-state level of the N-methyl-D-aspartate (NMDA) receptor subunit 2A without affecting the 2B subunit. The involvement of glutamate receptors was further suggested by the blockage of the effect of gambierol on tau hyperphosphorylation by glutamate receptor antagonists. The present study constitutes the first discovery of skeletally simplified, designed polycyclic ethers with potent cellular activity and demonstrates the utility of gambierol and its synthetic analogues as chemical probes for understanding the function of K-v channels as well as the molecular mechanism of A beta metabolism modulated by NMDA receptors.
    DOI:
    10.1021/ja300565t
  • 作为产物:
    描述:
    参考文献:
    名称:
    Design and Synthesis of Skeletal Analogues of Gambierol: Attenuation of Amyloid-β and Tau Pathology with Voltage-Gated Potassium Channel and N-Methyl-d-aspartate Receptor Implications
    摘要:
    Gambierol is a potent neurotoxin that belongs to the family of marine polycyclic ether natural products and primarily targets voltage-gated potassium channels (K-v channels) in excitable membranes. Previous work in the chemistry of marine polycyclic ethers has suggested the critical importance of the full length of polycyclic ether skeleton for potent biological activity. Although we have previously investigated structure-activity relationships (SARs) of the peripheral functionalities of gambierol, it remained unclear whether the whole polycyclic ether skeleton is needed for its cellular activity. In this work, we designed and synthesized two truncated skeletal analogues of gambierol comprising the EFGH- and BCDEFGH-rings of the parent compound, both of which surprisingly showed similar potency to gambierol on voltage gated potassium channels (K-v) inhibition. Moreover, we examined the effect of these compounds in an in vitro model of Alzheimer's disease (AD) obtained from triple transgenic (3xTg-AD) mice, which expresses amyloid beta (A beta) accumulation and tau hyperphosphorylation. In vitro preincubation of the cells with the compounds resulted in significant inhibition of K+ currents, a reduction in the extra- and intracellular levels of A beta, and a decrease in the levels of hyperphosphorylated tau. In addition, pretreatment with these compounds reduced the steady-state level of the N-methyl-D-aspartate (NMDA) receptor subunit 2A without affecting the 2B subunit. The involvement of glutamate receptors was further suggested by the blockage of the effect of gambierol on tau hyperphosphorylation by glutamate receptor antagonists. The present study constitutes the first discovery of skeletally simplified, designed polycyclic ethers with potent cellular activity and demonstrates the utility of gambierol and its synthetic analogues as chemical probes for understanding the function of K-v channels as well as the molecular mechanism of A beta metabolism modulated by NMDA receptors.
    DOI:
    10.1021/ja300565t
点击查看最新优质反应信息

同类化合物

苯甲基-2-乙酰氨基-4,6-O-苯亚甲基-2-脱氧-Alpha-D-吡喃葡萄糖苷 苯-1,2-二基二(磷羧酸酯) 苄基N-乙酰基-4,6-O-亚苄基-alpha-异胞壁酸 苄基4-氰基-4-脱氧-2,3-O-[(1S,2S)-1,2-二甲氧基-1,2-二甲基-1,2-乙二基]-beta-D-阿拉伯糖吡喃糖苷 苄基4,6-O-亚苄基吡喃己糖苷 苄基3-O-苄基-4,6-O-亚苄基吡喃己糖苷 苄基2-乙酰氨基-4,6-O-亚苄基-3-O-(羧甲基)-2-脱氧吡喃己糖苷 苄基2-乙酰氨基-4,6-O-亚苄基-2-脱氧-alpha-D-吡喃葡萄糖苷3-乙酸酯 苄基2-乙酰氨基-4,6-O-亚苄基-2-脱氧-3-O-(1-甲氧基-1-氧代-2-丙基)-beta-D-吡喃葡萄糖苷 苄基(5Xi)-2-乙酰氨基-2-脱氧-4,6-O-异亚丙基-alpha-D-来苏-吡喃己糖苷 苄基 4,6-O-亚苄基-beta-D-吡喃半乳糖苷 苄基 4,6-O-亚苄基-alpha-D-吡喃甘露糖苷 苄基 4,6-O-亚苄基-alpha-D-吡喃半乳糖苷 苄基 4,6-O-亚苄基-2,3-二-O-苄基-alpha-D-吡喃半乳糖苷 苄基 2-乙酰氨基-2-脱氧-4,6-O-异亚丙基-beta-D-吡喃葡萄糖苷 苄基 2-乙酰氨基-2-脱氧-4,6-O-亚苄基-alpha-D-吡喃半乳糖苷 苄基 2-O-苄基-4,6-O-亚苄基-alpha-D-吡喃甘露糖苷 苄基 2,3-二-O-苄基-4,6-O-亚苄基-beta-D-吡喃葡萄糖苷 苄基 2,3-二-O-(苯基甲基)-4,6-O-(苯基亚甲基)-ALPHA-D-吡喃甘露糖苷 甲基4-O,6-O-(苯基亚甲基)-2,3-二脱氧-alpha-D-赤式-吡喃己糖苷 甲基4,6-O-异亚丙基吡喃己糖苷 甲基4,6-O-异亚丙基-beta-D-吡喃半乳糖苷 甲基4,6-O-亚苄基-3-脱氧-3-硝基-beta-D-吡喃葡萄糖苷 甲基4,6-O-亚乙基-alpha-D-吡喃葡萄糖苷 甲基4,6-O-[(4-甲氧基苯基)亚甲基]-2,3-二-O-(苯基甲基)-ALPHA-D-吡喃葡萄糖苷 甲基4,6-O-[(4-甲氧基苯基)亚甲基]-2,3-二-O-(苯基甲基)-ALPHA-D-吡喃半乳糖苷 甲基3-O-苯甲酰基-4,6-O-亚苄基-beta-D-吡喃半乳糖苷 甲基3-O-苯甲酰基-4,6-O-亚苄基-alpha-D-吡喃葡萄糖苷 甲基2.3-二-O-苯甲酸基-4,6-O-亚苄基-β-D-喃葡萄苷 甲基2-乙酰氨基-4,6-O-亚苄基-2-脱氧吡喃己糖苷 甲基2-O-苯甲酰基-4,6-O-亚苄基-beta-D-吡喃葡萄糖苷 甲基2-O-烯丙基-3-O-苄基-4,6-O-亚苄基吡喃己糖苷 甲基2,3-O-二烯丙基-4,6-O-亚苄基-alpha-D-吡喃甘露糖苷 甲基-4,6-O-亚苄基-Α-D-吡喃葡糖苷 甲基-2,3-二-O-苯甲酰基-4,6-O-苯亚甲基-α-D-吡喃葡萄糖苷 甲基 4,6-O-亚苄基-β-D-吡喃葡萄糖苷 甲基 4,6-O-亚苄基-3-O-甲基-alpha-D-吡喃甘露糖苷 甲基 4,6-O-[(4-甲氧基苯基)亚甲基]-ALPHA-D-吡喃葡萄糖苷二乙酸酯 甲基 4,6-O-(苯基亚甲基)-alpha-D-吡喃葡萄糖苷 2-苯甲酸酯 甲基 4,6-O-(苯基亚甲基)-ALPHA-D-吡喃半乳糖苷二乙酸酯 甲基 3-O-苯甲酰基-4,6-O-亚苄基-beta-D-吡喃甘露糖苷 甲基 3-O-烯丙基-4,6-O-亚苄基-alpha-D-吡喃甘露糖苷 甲基 2,3-二苯甲酰-4,6-O-亚苄基-beta-D-吡喃半乳糖苷 烯丙基-4,6-O-苯亚甲基-α-D-吡喃葡萄糖苷 烯丙基-4,6-O-亚苄基-beta-D-吡喃葡萄糖苷 山海绵酰胺A 对硝基苯基 2-乙酰氨基-4,6-O-亚苄基-2-脱氧-beta-D-吡喃葡萄糖苷 亚苄基葡萄糖 二甲基二烯丙基氯化铵-丙烯酰胺共聚物 乙基 4,6-O-亚苄基吡喃己糖苷